I always thought Lyme was indifferent to gender. I assumed it was a differentiator between Lyme and ME/CFS, but perhaps that's not correct, at least to a certain degree.
I want to say they ruled out new infections, but I'm not sure. Are these re-activations of latent Bb, or new infections? I think it's pretty clear they are re-activations. So 5% of treated population retained Bb that later gets activated, and 90% of those are female? You have to assume more of the population carries latent Bb than just those 5%, of course.
Cool study that raises all sorts of questions.